<DOC>
	<DOCNO>NCT02543632</DOCNO>
	<brief_summary>Prospective , multi-center , post-market , non-randomized , nested-control , observational study CE mark CardioKinetix Parachute Implant System .</brief_summary>
	<brief_title>PARACHUTE V PercutAneous Ventricular RestorAtion Chronic Heart FailUre Due Ischemic HearT DiseasE .</brief_title>
	<detailed_description>Prospective , multi-center , post-market , non-randomized , nested-control , observational study European Conformity Approved ( CE mark ) CardioKinetix Parachute Implant System . The primary objective establish quality-of-life cardiac output benefit Parachute Implant patient present symptom heart failure due ischemic heart disease . A maximum 105 treated patient approximately 25 control patient may enrol , maximum 25 treated patient enrol one center . The Primary Endpoint improvement Quality Life patient treat Parachute Implant 6 month compare baseline use Minnesota Living Heart Failure ( MLWHF ) Questionnaire . The Secondary Endpoint improvement Stroke Volume Index ( mL/m2 ) patient treat Parachute Implant post-procedure compare pre-procedure .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<criteria>Post MI structural heart dysfunction represent left ventricular ( LV ) wall motion abnormality ( WMA ) Symptomatic Heart Failure reduce Ejection Fraction ( EF ) ( â‰¤ 40 % ) Receiving stable medication heart failure accord European Society Cardiology ( ESC ) Heart Failure ( HF ) Guidelines &gt; 18 year age Provide write informed consent Agree protocolrequired followup Acute myocardial infarction ( MI ) leave anterior descend territory within 90 day enrollment patient suspect evolve MI time enrollment Cardiogenic shock within 72 hour enrollment A known hypersensitivity contraindication aspirin , warfarin , nitinol ( titanium nickel alloy ) , sensitivity contrast medium , adequately pre medicate Other hemodynamically structural heart intervention heart failure device treatment time Parachute implant , e.g . mitral valve clip cardiac resynchronization therapy ) . Comorbidities associate life expectancy le 12months Treatment Arm ( Control Arm exclude criterion ) : Anatomical characteristic suitable treatment Parachute Implant device screen magnetic resonance imaging ( MRI ) computerize tomography ( CT ) . ( Characteristics include inappropriate size shape leave ventricle , pseudo chordae trabeculations interfere device placement . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>heart failure</keyword>
	<keyword>parachute</keyword>
	<keyword>partition device</keyword>
</DOC>